ESYN
HWH International Inc.
There isn't enough reported data to score ESYN yet.
LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
ESYN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Weak | |
| Strong |
ESYN's balance sheet is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its revenue.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ESYN PE Valuation
ESYN has no meaningful PE right now: it lost money over the past year.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
ESYN Forward outlook
There aren't enough analyst estimates for ESYN to show an outlook.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ESYN Earnings Per Share
ESYN and LCID do not have enough comparable growth data to identify a winner.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
ESYN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $64.2K | -79% |
| Q4 2025 | $54.6K | -81% |
| Q3 2025 | $206.8K | -40% |
| Q2 2025 | $310.4K | -7.3% |
| Q3 2024 | $345.5K | +52% |
| Q2 2024 | $334.9K | +48% |
| Q2 2022 | $66.5K | -96% |
| Q1 2022 | $647.7K | -62% |
ESYN's revenue has slid since its 2021 peak: $64,200 last quarter, down 79% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 328% | +304 points |
| Q1 2026 | -976% | N/A |
| Q4 2025 | -3569% | -3455 points |
| Q3 2025 | -143% | +13 points |
| Q2 2025 | 24% | +145 points |
| Q4 2024 | -115% | N/A |
| Q3 2024 | -155% | +19 points |
| Q2 2024 | -121% | N/A |
ESYN has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over ESYN in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
ESYN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$1M | -$765.8K |
| Q3 2025 | -$217.9K | +$59.2K |
| Q4 2024 | -$256.2K | -$25.7K |
| Q3 2024 | -$277.1K | +$196.7K |
| Q2 2024 | -$516.8K | -$43K |
| Q3 2023 | -$473.8K | -$367.6K |
| Q3 2022 | -$106.2K | +$364.7K |
| Q2 2022 | -$88.6K | -113% |
ESYN has the stronger cash trend. Its trailing FCF is up 8.7% versus its history, compared with LCID at down 75%.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
ESYN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +63.2K shares |
| 1 year | +16% | +1.1M shares |
| 3 years | +235% | +5.3M shares |
ESYN has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | $1.00 |
| Q3 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
ESYN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2021 | -0.7x | Net Cash |
ESYN has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ESYN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.6 | Neutral |
| Stochastic | 23.9 | Neutral |
ESYN's weekly RSI is 44 (neutral) and its Stochastic is 24 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
ESYN PE vs Consumer Cyclical Sector
ESYN has no meaningful PE right now: it lost money over the past year.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
ESYN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.92 | 24% below |
| 20 week MA | $1.78 | 19% below |
| 50 week MA | $1.55 | 6.5% below |
| 100 week MA | $1.67 | 13% below |
LCID has stronger trend alignment. ESYN is above 0 of 4 weekly averages versus LCID above 0 of 5.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
ESYN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $10.3 | $3.18 | -69% |
| 2025 | $3.18 | $1.49 | -53% |
| 2026 YTD | $1.49 | $1.45 | -2.7% |
ESYN has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.